|
- Stéatohépatite non alcoolique (NASH) : symptômes et complications
Le traitement de première intention du MASH (anciennement appelé NASH) consiste à perdre du poids en combinant une alimentation saine, une diminution de l'apport calorique et une augmentation de l'activité physique
- Nonalcoholic Steatohepatitis Treatment - American Liver Foundation
MASH used to be called NASH, or nonalcoholic steatohepatitis The first line of treatment for MASLD and MASH is weight loss through a combination of choosing healthy foods, eating fewer calories, and increasing physical activity
- Nichtalkoholische Steatohepatitis (NASH): Symptome und Komplikationen
Die metabolische Dysfunktions-assoziierte Steatohepatitis (MASH, früher NASH genannt) ist in der Regel symptomfrei Manche Patienten verspüren jedoch Müdigkeit oder Schmerzen im rechten Oberbauch, wo sich die Leber befindet
- Esteato-hepatite não alcoólica (NASH): sintomas e complicações
A esteato-hepatite associada à disfunção metabólica, ou MASH (anteriormente chamada de esteato-hepatite não alcoólica, ou NASH), é uma forma perigosamente progressiva de esteatose hepática, na qual os pacientes apresentam inflamação e danos ao fígado, atribuídos ao excesso de gordura (esteatose)
- 非酒精性脂肪性肝炎 (NASH)：症状和并发症
代谢功能障碍相关脂肪性肝炎，或称 MASH（以前称为非酒精性脂肪性肝炎，或称 NASH），是一种危险的进行性脂肪肝，患者因过多的脂肪（脂肪变性）而出现肝脏炎症和肝脏损伤。
- NASH Diagnosis: Testing Methods Procedures - American Liver Foundation
NASH is diagnosed when examination of the tissue with a microscope shows fat along with inflammation and damage to liver cells If the tissue shows fat without inflammation and damage, simple fatty liver or NAFLD is diagnosed
- Nonalcoholic Fatty Liver Disease (NAFLD)
MASH used to be known as NASH, or nonalcoholic steatohepatitis Over time, inflammation can lead to scarring in the liver and progress to a irreversible buildup of scarring, known as cirrhosis
- MASH* Causes and Risk Factors - American Liver Foundation
These diseases were formerly called nonalcoholic fatty liver disease and nonalcoholic steatohepatitis (NAFLD and NASH) Metabolic syndrome is a mix of conditions linked to being overweight or obese, and it makes people more likely to get type 2 diabetes and heart disease
|
|
|